nodes	percent_of_prediction	percent_of_DWPC	metapath
Orlistat—CYP3A4—Clindamycin—malaria	0.111	0.268	CbGbCtD
Orlistat—CYP3A4—Sulfadiazine—malaria	0.0639	0.154	CbGbCtD
Orlistat—CYP3A4—Artemether—malaria	0.0543	0.131	CbGbCtD
Orlistat—CYP3A4—Proguanil—malaria	0.0511	0.123	CbGbCtD
Orlistat—CYP3A4—Doxycycline—malaria	0.0484	0.116	CbGbCtD
Orlistat—CYP3A4—Quinine—malaria	0.0329	0.0792	CbGbCtD
Orlistat—CYP3A4—Quinidine—malaria	0.0289	0.0696	CbGbCtD
Orlistat—CYP3A4—Dapsone—malaria	0.0249	0.06	CbGbCtD
Orlistat—LIPF—Fatty Acid Beta Oxidation—DECR1—malaria	0.0242	0.187	CbGpPWpGaD
Orlistat—FASN—ChREBP activates metabolic gene expression—PKLR—malaria	0.0191	0.147	CbGpPWpGaD
Orlistat—PLA2G7—blood plasma—malaria	0.0152	0.0758	CbGeAlD
Orlistat—LIPF—digestive system—malaria	0.0145	0.0722	CbGeAlD
Orlistat—PNLIP—blood plasma—malaria	0.0134	0.0666	CbGeAlD
Orlistat—FASN—Fatty Acid Biosynthesis—DECR1—malaria	0.0106	0.0814	CbGpPWpGaD
Orlistat—DAGLA—blood—malaria	0.00891	0.0443	CbGeAlD
Orlistat—DAGLB—kidney—malaria	0.00855	0.0425	CbGeAlD
Orlistat—PLA2G7—hematopoietic system—malaria	0.00842	0.0419	CbGeAlD
Orlistat—ABHD16A—saliva-secreting gland—malaria	0.00828	0.0412	CbGeAlD
Orlistat—ABHD12—saliva-secreting gland—malaria	0.00776	0.0386	CbGeAlD
Orlistat—PLA2G7—IL1 and megakaryotyces in obesity—IL18—malaria	0.00753	0.058	CbGpPWpGaD
Orlistat—PNLIP—hematopoietic system—malaria	0.0074	0.0368	CbGeAlD
Orlistat—FASN—saliva-secreting gland—malaria	0.00651	0.0324	CbGeAlD
Orlistat—PLA2G7—IL1 and megakaryotyces in obesity—ICAM1—malaria	0.0058	0.0447	CbGpPWpGaD
Orlistat—PLA2G7—blood—malaria	0.00558	0.0278	CbGeAlD
Orlistat—DAGLA—brain—malaria	0.00553	0.0275	CbGeAlD
Orlistat—PLA2G4A—blood plasma—malaria	0.0054	0.0269	CbGeAlD
Orlistat—DAGLB—liver—malaria	0.0054	0.0269	CbGeAlD
Orlistat—PLA2G7—bone marrow—malaria	0.0054	0.0269	CbGeAlD
Orlistat—ABHD16A—blood—malaria	0.00524	0.026	CbGeAlD
Orlistat—PNLIP—digestive system—malaria	0.00515	0.0256	CbGeAlD
Orlistat—ABHD16A—bone marrow—malaria	0.00507	0.0252	CbGeAlD
Orlistat—ABHD12—blood—malaria	0.00491	0.0244	CbGeAlD
Orlistat—PNLIP—blood—malaria	0.00491	0.0244	CbGeAlD
Orlistat—PLA2G7—IL1 and megakaryotyces in obesity—IFNG—malaria	0.00441	0.034	CbGpPWpGaD
Orlistat—PLA2G7—liver—malaria	0.00436	0.0217	CbGeAlD
Orlistat—DAGLB—brain—malaria	0.00429	0.0213	CbGeAlD
Orlistat—FASN—blood—malaria	0.00412	0.0205	CbGeAlD
Orlistat—PLA2G7—IL1 and megakaryotyces in obesity—IL1B—malaria	0.00394	0.0303	CbGpPWpGaD
Orlistat—PNLIP—Lipid and lipoprotein metabolism—SCARB1—malaria	0.00389	0.03	CbGpPWpGaD
Orlistat—ABHD12—liver—malaria	0.00384	0.0191	CbGeAlD
Orlistat—PNLIP—liver—malaria	0.00384	0.0191	CbGeAlD
Orlistat—PLA2G7—brain—malaria	0.00346	0.0172	CbGeAlD
Orlistat—FASN—liver—malaria	0.00322	0.016	CbGeAlD
Orlistat—PLA2G4A—saliva-secreting gland—malaria	0.00313	0.0156	CbGeAlD
Orlistat—ABHD12—brain—malaria	0.00304	0.0151	CbGeAlD
Orlistat—PLA2G4A—hematopoietic system—malaria	0.00299	0.0149	CbGeAlD
Orlistat—FASN—brain—malaria	0.00255	0.0127	CbGeAlD
Orlistat—FASN—Integration of energy metabolism—PKLR—malaria	0.00246	0.0189	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—NANP—malaria	0.00214	0.0165	CbGpPWpGaD
Orlistat—FASN—SREBP signalling—SCARB1—malaria	0.00213	0.0164	CbGpPWpGaD
Orlistat—PLA2G4A—blood—malaria	0.00198	0.00985	CbGeAlD
Orlistat—FASN—Fatty acid, triacylglycerol, and ketone body metabolism—DECR1—malaria	0.00197	0.0151	CbGpPWpGaD
Orlistat—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—FCGR2B—malaria	0.00195	0.015	CbGpPWpGaD
Orlistat—PLA2G4A—bone marrow—malaria	0.00191	0.00953	CbGeAlD
Orlistat—FASN—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—malaria	0.00179	0.0138	CbGpPWpGaD
Orlistat—CYP3A4—blood plasma—malaria	0.00178	0.00887	CbGeAlD
Orlistat—PLA2G4A—AGE/RAGE pathway—TIRAP—malaria	0.00163	0.0126	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—HBB—malaria	0.00133	0.0102	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—HBB—malaria	0.00133	0.0102	CbGpPWpGaD
Orlistat—PLA2G4A—Arachidonic acid metabolism—HPGDS—malaria	0.00129	0.00992	CbGpPWpGaD
Orlistat—PLA2G4A—brain—malaria	0.00123	0.00611	CbGeAlD
Orlistat—FASN—p73 transcription factor network—FAS—malaria	0.00115	0.00888	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—DECR1—malaria	0.00111	0.00852	CbGpPWpGaD
Orlistat—Asthma—Quinidine—malaria	0.0011	0.00433	CcSEcCtD
Orlistat—Asthma—Quinine—malaria	0.0011	0.00433	CcSEcCtD
Orlistat—Bronchospasm—Quinine—malaria	0.00108	0.00426	CcSEcCtD
Orlistat—Bronchospasm—Quinidine—malaria	0.00108	0.00426	CcSEcCtD
Orlistat—Abdominal discomfort—Clindamycin—malaria	0.00107	0.00423	CcSEcCtD
Orlistat—Gastrointestinal pain—Proguanil—malaria	0.00105	0.00415	CcSEcCtD
Orlistat—Vomiting—Pyrimethamine—malaria	0.00105	0.00415	CcSEcCtD
Orlistat—Abdominal pain upper—Quinidine barbiturate—malaria	0.00105	0.00413	CcSEcCtD
Orlistat—Upper respiratory tract infection—Clindamycin—malaria	0.00104	0.0041	CcSEcCtD
Orlistat—Breast disorder—Quinidine barbiturate—malaria	0.00104	0.00409	CcSEcCtD
Orlistat—Body temperature increased—Proguanil—malaria	0.00102	0.00402	CcSEcCtD
Orlistat—Abdominal pain—Proguanil—malaria	0.00102	0.00402	CcSEcCtD
Orlistat—Neuropathy peripheral—Dapsone—malaria	0.00101	0.00399	CcSEcCtD
Orlistat—Abdominal distension—Pentoxifylline—malaria	0.000996	0.00393	CcSEcCtD
Orlistat—Asthma—Quinidine barbiturate—malaria	0.000991	0.00391	CcSEcCtD
Orlistat—CYP3A4—hematopoietic system—malaria	0.000985	0.0049	CbGeAlD
Orlistat—Bronchospasm—Quinidine barbiturate—malaria	0.000975	0.00385	CcSEcCtD
Orlistat—Bronchospasm—Pentoxifylline—malaria	0.000973	0.00384	CcSEcCtD
Orlistat—Urinary tract infection—Clindamycin—malaria	0.00097	0.00383	CcSEcCtD
Orlistat—Sinusitis—Dapsone—malaria	0.000968	0.00382	CcSEcCtD
Orlistat—Renal failure—Quinine—malaria	0.000963	0.0038	CcSEcCtD
Orlistat—Renal failure—Quinidine—malaria	0.000963	0.0038	CcSEcCtD
Orlistat—Abdominal discomfort—Pentoxifylline—malaria	0.000949	0.00374	CcSEcCtD
Orlistat—Vertigo—Sulfadiazine—malaria	0.000941	0.00371	CcSEcCtD
Orlistat—Pharyngitis—Dapsone—malaria	0.000919	0.00363	CcSEcCtD
Orlistat—Convulsion—Sulfadiazine—malaria	0.000908	0.00358	CcSEcCtD
Orlistat—DAGLB—Platelet activation, signaling and aggregation—CD36—malaria	0.000898	0.00692	CbGpPWpGaD
Orlistat—DAGLA—Platelet activation, signaling and aggregation—CD36—malaria	0.000898	0.00692	CbGpPWpGaD
Orlistat—Haemoglobin—Quinidine—malaria	0.000884	0.00349	CcSEcCtD
Orlistat—Haemoglobin—Quinine—malaria	0.000884	0.00349	CcSEcCtD
Orlistat—Infestation NOS—Pentoxifylline—malaria	0.000882	0.00348	CcSEcCtD
Orlistat—Infestation—Pentoxifylline—malaria	0.000882	0.00348	CcSEcCtD
Orlistat—Diarrhoea—Proguanil—malaria	0.000881	0.00348	CcSEcCtD
Orlistat—Haemorrhage—Quinidine—malaria	0.000879	0.00347	CcSEcCtD
Orlistat—Hepatitis—Quinidine—malaria	0.000879	0.00347	CcSEcCtD
Orlistat—Haemorrhage—Quinine—malaria	0.000879	0.00347	CcSEcCtD
Orlistat—Hepatitis—Quinine—malaria	0.000879	0.00347	CcSEcCtD
Orlistat—Renal failure—Quinidine barbiturate—malaria	0.000869	0.00343	CcSEcCtD
Orlistat—Urinary tract disorder—Quinidine—malaria	0.000868	0.00342	CcSEcCtD
Orlistat—Urinary tract disorder—Quinine—malaria	0.000868	0.00342	CcSEcCtD
Orlistat—Urethral disorder—Quinidine—malaria	0.000862	0.0034	CcSEcCtD
Orlistat—Urethral disorder—Quinine—malaria	0.000862	0.0034	CcSEcCtD
Orlistat—Anaphylactic shock—Sulfadiazine—malaria	0.000855	0.00337	CcSEcCtD
Orlistat—Hepatobiliary disease—Pentoxifylline—malaria	0.000834	0.00329	CcSEcCtD
Orlistat—Vomiting—Proguanil—malaria	0.000819	0.00323	CcSEcCtD
Orlistat—Rash—Proguanil—malaria	0.000812	0.0032	CcSEcCtD
Orlistat—Dermatitis—Proguanil—malaria	0.000811	0.0032	CcSEcCtD
Orlistat—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—NOS2—malaria	0.000811	0.00625	CbGpPWpGaD
Orlistat—CYP3A4—kidney—malaria	0.000808	0.00402	CbGeAlD
Orlistat—Headache—Proguanil—malaria	0.000807	0.00318	CcSEcCtD
Orlistat—Haemoglobin—Quinidine barbiturate—malaria	0.000797	0.00315	CcSEcCtD
Orlistat—Haemoglobin—Pentoxifylline—malaria	0.000796	0.00314	CcSEcCtD
Orlistat—Immune system disorder—Quinidine—malaria	0.000794	0.00313	CcSEcCtD
Orlistat—Immune system disorder—Quinine—malaria	0.000794	0.00313	CcSEcCtD
Orlistat—Haemorrhage—Quinidine barbiturate—malaria	0.000793	0.00313	CcSEcCtD
Orlistat—Hepatitis—Quinidine barbiturate—malaria	0.000793	0.00313	CcSEcCtD
Orlistat—Mediastinal disorder—Quinidine—malaria	0.000792	0.00313	CcSEcCtD
Orlistat—Mediastinal disorder—Quinine—malaria	0.000792	0.00313	CcSEcCtD
Orlistat—Haemorrhage—Pentoxifylline—malaria	0.000792	0.00312	CcSEcCtD
Orlistat—Hepatitis—Pentoxifylline—malaria	0.000792	0.00312	CcSEcCtD
Orlistat—Urinary tract disorder—Quinidine barbiturate—malaria	0.000784	0.00309	CcSEcCtD
Orlistat—FASN—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000783	0.00603	CbGpPWpGaD
Orlistat—Musculoskeletal discomfort—Sulfadiazine—malaria	0.000779	0.00307	CcSEcCtD
Orlistat—Urethral disorder—Quinidine barbiturate—malaria	0.000778	0.00307	CcSEcCtD
Orlistat—Insomnia—Sulfadiazine—malaria	0.000773	0.00305	CcSEcCtD
Orlistat—Mental disorder—Quinidine—malaria	0.00077	0.00304	CcSEcCtD
Orlistat—Mental disorder—Quinine—malaria	0.00077	0.00304	CcSEcCtD
Orlistat—Flatulence—Clindamycin—malaria	0.000769	0.00303	CcSEcCtD
Orlistat—Malnutrition—Quinidine—malaria	0.000765	0.00302	CcSEcCtD
Orlistat—Malnutrition—Quinine—malaria	0.000765	0.00302	CcSEcCtD
Orlistat—Nausea—Proguanil—malaria	0.000765	0.00302	CcSEcCtD
Orlistat—Dysgeusia—Clindamycin—malaria	0.000764	0.00301	CcSEcCtD
Orlistat—Vision blurred—Dapsone—malaria	0.00076	0.003	CcSEcCtD
Orlistat—Back pain—Clindamycin—malaria	0.000755	0.00298	CcSEcCtD
Orlistat—Muscle spasms—Clindamycin—malaria	0.00075	0.00296	CcSEcCtD
Orlistat—Decreased appetite—Sulfadiazine—malaria	0.000743	0.00293	CcSEcCtD
Orlistat—Gastrointestinal disorder—Sulfadiazine—malaria	0.000738	0.00291	CcSEcCtD
Orlistat—Vertigo—Dapsone—malaria	0.000725	0.00286	CcSEcCtD
Orlistat—Vision blurred—Quinine—malaria	0.000721	0.00284	CcSEcCtD
Orlistat—Vision blurred—Quinidine—malaria	0.000721	0.00284	CcSEcCtD
Orlistat—Immune system disorder—Quinidine barbiturate—malaria	0.000717	0.00283	CcSEcCtD
Orlistat—DAGLA—Signaling by GPCR—ACKR1—malaria	0.000715	0.00551	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—ACKR1—malaria	0.000715	0.00551	CbGpPWpGaD
Orlistat—Immune system disorder—Pentoxifylline—malaria	0.000715	0.00282	CcSEcCtD
Orlistat—Mediastinal disorder—Quinidine barbiturate—malaria	0.000715	0.00282	CcSEcCtD
Orlistat—Cough—Dapsone—malaria	0.000704	0.00278	CcSEcCtD
Orlistat—Vertigo—Clindamycin—malaria	0.000701	0.00276	CcSEcCtD
Orlistat—Angioedema—Quinine—malaria	0.000699	0.00276	CcSEcCtD
Orlistat—Angioedema—Quinidine—malaria	0.000699	0.00276	CcSEcCtD
Orlistat—Gastrointestinal pain—Sulfadiazine—malaria	0.000699	0.00276	CcSEcCtD
Orlistat—Mental disorder—Quinidine barbiturate—malaria	0.000695	0.00274	CcSEcCtD
Orlistat—Malnutrition—Quinidine barbiturate—malaria	0.000691	0.00272	CcSEcCtD
Orlistat—Vertigo—Quinidine—malaria	0.000688	0.00271	CcSEcCtD
Orlistat—Vertigo—Quinine—malaria	0.000688	0.00271	CcSEcCtD
Orlistat—CYP3A4—digestive system—malaria	0.000685	0.00341	CbGeAlD
Orlistat—Flatulence—Pentoxifylline—malaria	0.000679	0.00268	CcSEcCtD
Orlistat—Urticaria—Sulfadiazine—malaria	0.000679	0.00268	CcSEcCtD
Orlistat—Palpitations—Quinine—malaria	0.000676	0.00267	CcSEcCtD
Orlistat—Palpitations—Quinidine—malaria	0.000676	0.00267	CcSEcCtD
Orlistat—Body temperature increased—Sulfadiazine—malaria	0.000676	0.00267	CcSEcCtD
Orlistat—Abdominal pain—Sulfadiazine—malaria	0.000676	0.00267	CcSEcCtD
Orlistat—Dysgeusia—Pentoxifylline—malaria	0.000675	0.00266	CcSEcCtD
Orlistat—Back pain—Pentoxifylline—malaria	0.000667	0.00263	CcSEcCtD
Orlistat—Convulsion—Quinine—malaria	0.000663	0.00262	CcSEcCtD
Orlistat—Convulsion—Quinidine—malaria	0.000663	0.00262	CcSEcCtD
Orlistat—Muscle spasms—Pentoxifylline—malaria	0.000663	0.00261	CcSEcCtD
Orlistat—Discomfort—Clindamycin—malaria	0.000656	0.00259	CcSEcCtD
Orlistat—CYP3A4—blood—malaria	0.000653	0.00325	CbGeAlD
Orlistat—Chest pain—Quinidine—malaria	0.000652	0.00257	CcSEcCtD
Orlistat—Myalgia—Quinine—malaria	0.000652	0.00257	CcSEcCtD
Orlistat—Myalgia—Quinidine—malaria	0.000652	0.00257	CcSEcCtD
Orlistat—Chest pain—Quinine—malaria	0.000652	0.00257	CcSEcCtD
Orlistat—Vision blurred—Quinidine barbiturate—malaria	0.000651	0.00257	CcSEcCtD
Orlistat—Vision blurred—Pentoxifylline—malaria	0.00065	0.00256	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000647	0.00255	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000647	0.00255	CcSEcCtD
Orlistat—Ill-defined disorder—Pentoxifylline—malaria	0.00064	0.00252	CcSEcCtD
Orlistat—Anaphylactic shock—Clindamycin—malaria	0.000637	0.00251	CcSEcCtD
Orlistat—Angioedema—Quinidine barbiturate—malaria	0.000631	0.00249	CcSEcCtD
Orlistat—Angioedema—Pentoxifylline—malaria	0.00063	0.00248	CcSEcCtD
Orlistat—Hypersensitivity—Sulfadiazine—malaria	0.00063	0.00248	CcSEcCtD
Orlistat—Oedema—Quinidine—malaria	0.000625	0.00246	CcSEcCtD
Orlistat—Oedema—Quinine—malaria	0.000625	0.00246	CcSEcCtD
Orlistat—Malaise—Pentoxifylline—malaria	0.000622	0.00245	CcSEcCtD
Orlistat—Vertigo—Quinidine barbiturate—malaria	0.000621	0.00245	CcSEcCtD
Orlistat—FASN—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—malaria	0.00062	0.00478	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—DHODH—malaria	0.000616	0.00475	CbGpPWpGaD
Orlistat—Nervous system disorder—Quinine—malaria	0.000613	0.00242	CcSEcCtD
Orlistat—Nervous system disorder—Quinidine—malaria	0.000613	0.00242	CcSEcCtD
Orlistat—Palpitations—Quinidine barbiturate—malaria	0.00061	0.00241	CcSEcCtD
Orlistat—Palpitations—Pentoxifylline—malaria	0.000609	0.0024	CcSEcCtD
Orlistat—Skin disorder—Quinidine—malaria	0.000607	0.00239	CcSEcCtD
Orlistat—Skin disorder—Quinine—malaria	0.000607	0.00239	CcSEcCtD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—HPGDS—malaria	0.000606	0.00467	CbGpPWpGaD
Orlistat—Pruritus—Sulfadiazine—malaria	0.000605	0.00239	CcSEcCtD
Orlistat—Hyperhidrosis—Quinidine—malaria	0.000604	0.00238	CcSEcCtD
Orlistat—Hyperhidrosis—Quinine—malaria	0.000604	0.00238	CcSEcCtD
Orlistat—Convulsion—Quinidine barbiturate—malaria	0.000598	0.00236	CcSEcCtD
Orlistat—Convulsion—Pentoxifylline—malaria	0.000597	0.00236	CcSEcCtD
Orlistat—Insomnia—Dapsone—malaria	0.000595	0.00235	CcSEcCtD
Orlistat—Myalgia—Quinidine barbiturate—malaria	0.000588	0.00232	CcSEcCtD
Orlistat—Chest pain—Quinidine barbiturate—malaria	0.000588	0.00232	CcSEcCtD
Orlistat—Chest pain—Pentoxifylline—malaria	0.000587	0.00232	CcSEcCtD
Orlistat—Myalgia—Pentoxifylline—malaria	0.000587	0.00232	CcSEcCtD
Orlistat—Anxiety—Quinidine barbiturate—malaria	0.000586	0.00231	CcSEcCtD
Orlistat—Diarrhoea—Sulfadiazine—malaria	0.000585	0.00231	CcSEcCtD
Orlistat—Anxiety—Pentoxifylline—malaria	0.000585	0.00231	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000584	0.0023	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000583	0.0023	CcSEcCtD
Orlistat—Discomfort—Pentoxifylline—malaria	0.00058	0.00229	CcSEcCtD
Orlistat—Dry mouth—Pentoxifylline—malaria	0.000574	0.00226	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Quinine—malaria	0.000569	0.00224	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Quinidine—malaria	0.000569	0.00224	CcSEcCtD
Orlistat—Oedema—Quinidine barbiturate—malaria	0.000564	0.00222	CcSEcCtD
Orlistat—Anaphylactic shock—Pentoxifylline—malaria	0.000563	0.00222	CcSEcCtD
Orlistat—Oedema—Pentoxifylline—malaria	0.000563	0.00222	CcSEcCtD
Orlistat—Dyspepsia—Clindamycin—malaria	0.00056	0.00221	CcSEcCtD
Orlistat—Infection—Pentoxifylline—malaria	0.000559	0.0022	CcSEcCtD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—SCARB1—malaria	0.000556	0.00429	CbGpPWpGaD
Orlistat—Nervous system disorder—Quinidine barbiturate—malaria	0.000553	0.00218	CcSEcCtD
Orlistat—Gastrointestinal disorder—Clindamycin—malaria	0.00055	0.00217	CcSEcCtD
Orlistat—Fatigue—Clindamycin—malaria	0.000549	0.00217	CcSEcCtD
Orlistat—Skin disorder—Quinidine barbiturate—malaria	0.000548	0.00216	CcSEcCtD
Orlistat—Skin disorder—Pentoxifylline—malaria	0.000547	0.00216	CcSEcCtD
Orlistat—Hyperhidrosis—Quinidine barbiturate—malaria	0.000545	0.00215	CcSEcCtD
Orlistat—Pain—Clindamycin—malaria	0.000544	0.00215	CcSEcCtD
Orlistat—Hyperhidrosis—Pentoxifylline—malaria	0.000544	0.00215	CcSEcCtD
Orlistat—Vomiting—Sulfadiazine—malaria	0.000544	0.00214	CcSEcCtD
Orlistat—Decreased appetite—Quinine—malaria	0.000543	0.00214	CcSEcCtD
Orlistat—Decreased appetite—Quinidine—malaria	0.000543	0.00214	CcSEcCtD
Orlistat—Gastrointestinal disorder—Quinine—malaria	0.000539	0.00213	CcSEcCtD
Orlistat—Gastrointestinal disorder—Quinidine—malaria	0.000539	0.00213	CcSEcCtD
Orlistat—Rash—Sulfadiazine—malaria	0.000539	0.00213	CcSEcCtD
Orlistat—Dermatitis—Sulfadiazine—malaria	0.000539	0.00212	CcSEcCtD
Orlistat—Gastrointestinal pain—Dapsone—malaria	0.000538	0.00212	CcSEcCtD
Orlistat—Headache—Sulfadiazine—malaria	0.000536	0.00211	CcSEcCtD
Orlistat—PNLIP—Metabolism—SLC4A1—malaria	0.000524	0.00404	CbGpPWpGaD
Orlistat—Gastrointestinal pain—Clindamycin—malaria	0.000521	0.00205	CcSEcCtD
Orlistat—Abdominal pain—Dapsone—malaria	0.00052	0.00205	CcSEcCtD
Orlistat—Body temperature increased—Dapsone—malaria	0.00052	0.00205	CcSEcCtD
Orlistat—Feeling abnormal—Quinidine—malaria	0.000515	0.00203	CcSEcCtD
Orlistat—Feeling abnormal—Quinine—malaria	0.000515	0.00203	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000514	0.00203	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000513	0.00202	CcSEcCtD
Orlistat—Gastrointestinal pain—Quinidine—malaria	0.000511	0.00201	CcSEcCtD
Orlistat—Gastrointestinal pain—Quinine—malaria	0.000511	0.00201	CcSEcCtD
Orlistat—CYP3A4—liver—malaria	0.000511	0.00254	CbGeAlD
Orlistat—Insomnia—Pentoxifylline—malaria	0.000509	0.00201	CcSEcCtD
Orlistat—Nausea—Sulfadiazine—malaria	0.000508	0.002	CcSEcCtD
Orlistat—Urticaria—Clindamycin—malaria	0.000506	0.00199	CcSEcCtD
Orlistat—Abdominal pain—Clindamycin—malaria	0.000503	0.00199	CcSEcCtD
Orlistat—Body temperature increased—Clindamycin—malaria	0.000503	0.00199	CcSEcCtD
Orlistat—DAGLA—Platelet activation, signaling and aggregation—IL2—malaria	0.000503	0.00388	CbGpPWpGaD
Orlistat—DAGLB—Platelet activation, signaling and aggregation—IL2—malaria	0.000503	0.00388	CbGpPWpGaD
Orlistat—Urticaria—Quinine—malaria	0.000496	0.00196	CcSEcCtD
Orlistat—Urticaria—Quinidine—malaria	0.000496	0.00196	CcSEcCtD
Orlistat—Dyspepsia—Pentoxifylline—malaria	0.000495	0.00195	CcSEcCtD
Orlistat—Body temperature increased—Quinidine—malaria	0.000494	0.00195	CcSEcCtD
Orlistat—Abdominal pain—Quinidine—malaria	0.000494	0.00195	CcSEcCtD
Orlistat—Body temperature increased—Quinine—malaria	0.000494	0.00195	CcSEcCtD
Orlistat—Abdominal pain—Quinine—malaria	0.000494	0.00195	CcSEcCtD
Orlistat—PNLIP—Metabolism—DECR1—malaria	0.000493	0.0038	CbGpPWpGaD
Orlistat—Decreased appetite—Quinidine barbiturate—malaria	0.00049	0.00193	CcSEcCtD
Orlistat—Decreased appetite—Pentoxifylline—malaria	0.000489	0.00193	CcSEcCtD
Orlistat—PLA2G4A—AGE/RAGE pathway—NOS2—malaria	0.000488	0.00376	CbGpPWpGaD
Orlistat—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000487	0.00192	CcSEcCtD
Orlistat—Pain—Quinidine barbiturate—malaria	0.000482	0.0019	CcSEcCtD
Orlistat—PNLIP—Disease—PKLR—malaria	0.000474	0.00365	CbGpPWpGaD
Orlistat—Hypersensitivity—Clindamycin—malaria	0.000469	0.00185	CcSEcCtD
Orlistat—Feeling abnormal—Quinidine barbiturate—malaria	0.000465	0.00183	CcSEcCtD
Orlistat—Feeling abnormal—Pentoxifylline—malaria	0.000464	0.00183	CcSEcCtD
Orlistat—DAGLA—Hemostasis—CD36—malaria	0.000463	0.00357	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—CD36—malaria	0.000463	0.00357	CbGpPWpGaD
Orlistat—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000461	0.00182	CcSEcCtD
Orlistat—Hypersensitivity—Quinine—malaria	0.00046	0.00182	CcSEcCtD
Orlistat—Hypersensitivity—Quinidine—malaria	0.00046	0.00182	CcSEcCtD
Orlistat—Gastrointestinal pain—Pentoxifylline—malaria	0.00046	0.00181	CcSEcCtD
Orlistat—Asthenia—Clindamycin—malaria	0.000457	0.0018	CcSEcCtD
Orlistat—Pruritus—Clindamycin—malaria	0.00045	0.00178	CcSEcCtD
Orlistat—Asthenia—Quinine—malaria	0.000448	0.00177	CcSEcCtD
Orlistat—Asthenia—Quinidine—malaria	0.000448	0.00177	CcSEcCtD
Orlistat—Urticaria—Quinidine barbiturate—malaria	0.000448	0.00177	CcSEcCtD
Orlistat—Urticaria—Pentoxifylline—malaria	0.000447	0.00176	CcSEcCtD
Orlistat—Abdominal pain—Quinidine barbiturate—malaria	0.000446	0.00176	CcSEcCtD
Orlistat—Body temperature increased—Quinidine barbiturate—malaria	0.000446	0.00176	CcSEcCtD
Orlistat—PNLIP—Metabolism—HBB—malaria	0.000445	0.00343	CbGpPWpGaD
Orlistat—Body temperature increased—Pentoxifylline—malaria	0.000445	0.00175	CcSEcCtD
Orlistat—Abdominal pain—Pentoxifylline—malaria	0.000445	0.00175	CcSEcCtD
Orlistat—Pruritus—Quinine—malaria	0.000442	0.00174	CcSEcCtD
Orlistat—Pruritus—Quinidine—malaria	0.000442	0.00174	CcSEcCtD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	0.000441	0.0034	CbGpPWpGaD
Orlistat—FASN—Metabolism—DHODH—malaria	0.000436	0.00336	CbGpPWpGaD
Orlistat—Diarrhoea—Clindamycin—malaria	0.000436	0.00172	CcSEcCtD
Orlistat—FASN—Metabolism of lipids and lipoproteins—HPGDS—malaria	0.000429	0.0033	CbGpPWpGaD
Orlistat—Diarrhoea—Quinidine—malaria	0.000427	0.00169	CcSEcCtD
Orlistat—Diarrhoea—Quinine—malaria	0.000427	0.00169	CcSEcCtD
Orlistat—PLA2G4A—Platelet homeostasis—NOS2—malaria	0.000427	0.00329	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—ACKR1—malaria	0.000423	0.00326	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—ACKR1—malaria	0.000423	0.00326	CbGpPWpGaD
Orlistat—PNLIP—Disease—G6PD—malaria	0.000423	0.00326	CbGpPWpGaD
Orlistat—Dizziness—Clindamycin—malaria	0.000421	0.00166	CcSEcCtD
Orlistat—Vomiting—Dapsone—malaria	0.000418	0.00165	CcSEcCtD
Orlistat—Hypersensitivity—Quinidine barbiturate—malaria	0.000415	0.00164	CcSEcCtD
Orlistat—Hypersensitivity—Pentoxifylline—malaria	0.000415	0.00164	CcSEcCtD
Orlistat—Dizziness—Quinidine—malaria	0.000413	0.00163	CcSEcCtD
Orlistat—Dizziness—Quinine—malaria	0.000413	0.00163	CcSEcCtD
Orlistat—Headache—Dapsone—malaria	0.000412	0.00163	CcSEcCtD
Orlistat—Vomiting—Clindamycin—malaria	0.000405	0.0016	CcSEcCtD
Orlistat—Asthenia—Quinidine barbiturate—malaria	0.000404	0.0016	CcSEcCtD
Orlistat—Asthenia—Pentoxifylline—malaria	0.000404	0.00159	CcSEcCtD
Orlistat—Rash—Clindamycin—malaria	0.000401	0.00158	CcSEcCtD
Orlistat—Dermatitis—Clindamycin—malaria	0.000401	0.00158	CcSEcCtD
Orlistat—Headache—Clindamycin—malaria	0.000399	0.00157	CcSEcCtD
Orlistat—Pruritus—Quinidine barbiturate—malaria	0.000399	0.00157	CcSEcCtD
Orlistat—Pruritus—Pentoxifylline—malaria	0.000398	0.00157	CcSEcCtD
Orlistat—Vomiting—Quinidine—malaria	0.000397	0.00157	CcSEcCtD
Orlistat—Vomiting—Quinine—malaria	0.000397	0.00157	CcSEcCtD
Orlistat—PNLIP—Metabolism—PKLR—malaria	0.000397	0.00306	CbGpPWpGaD
Orlistat—Rash—Quinine—malaria	0.000394	0.00155	CcSEcCtD
Orlistat—Rash—Quinidine—malaria	0.000394	0.00155	CcSEcCtD
Orlistat—FASN—Metabolism of lipids and lipoproteins—SCARB1—malaria	0.000394	0.00303	CbGpPWpGaD
Orlistat—Dermatitis—Quinidine—malaria	0.000393	0.00155	CcSEcCtD
Orlistat—Dermatitis—Quinine—malaria	0.000393	0.00155	CcSEcCtD
Orlistat—Headache—Quinidine—malaria	0.000391	0.00154	CcSEcCtD
Orlistat—Headache—Quinine—malaria	0.000391	0.00154	CcSEcCtD
Orlistat—Nausea—Dapsone—malaria	0.000391	0.00154	CcSEcCtD
Orlistat—Diarrhoea—Quinidine barbiturate—malaria	0.000386	0.00152	CcSEcCtD
Orlistat—Diarrhoea—Pentoxifylline—malaria	0.000385	0.00152	CcSEcCtD
Orlistat—DAGLB—Hemostasis—NOS2—malaria	0.000381	0.00293	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—NOS2—malaria	0.000381	0.00293	CbGpPWpGaD
Orlistat—Nausea—Clindamycin—malaria	0.000378	0.00149	CcSEcCtD
Orlistat—Dizziness—Quinidine barbiturate—malaria	0.000373	0.00147	CcSEcCtD
Orlistat—Dizziness—Pentoxifylline—malaria	0.000372	0.00147	CcSEcCtD
Orlistat—Nausea—Quinidine—malaria	0.000371	0.00146	CcSEcCtD
Orlistat—Nausea—Quinine—malaria	0.000371	0.00146	CcSEcCtD
Orlistat—FASN—Metabolism—SLC4A1—malaria	0.000371	0.00286	CbGpPWpGaD
Orlistat—Vomiting—Quinidine barbiturate—malaria	0.000358	0.00141	CcSEcCtD
Orlistat—Vomiting—Pentoxifylline—malaria	0.000358	0.00141	CcSEcCtD
Orlistat—Rash—Quinidine barbiturate—malaria	0.000355	0.0014	CcSEcCtD
Orlistat—Dermatitis—Quinidine barbiturate—malaria	0.000355	0.0014	CcSEcCtD
Orlistat—Rash—Pentoxifylline—malaria	0.000355	0.0014	CcSEcCtD
Orlistat—Dermatitis—Pentoxifylline—malaria	0.000354	0.0014	CcSEcCtD
Orlistat—PNLIP—Metabolism—G6PD—malaria	0.000354	0.00273	CbGpPWpGaD
Orlistat—Headache—Quinidine barbiturate—malaria	0.000353	0.00139	CcSEcCtD
Orlistat—Headache—Pentoxifylline—malaria	0.000352	0.00139	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—ACKR1—malaria	0.00035	0.0027	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—CD36—malaria	0.000349	0.00269	CbGpPWpGaD
Orlistat—FASN—Metabolism—DECR1—malaria	0.000348	0.00269	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—TLR9—malaria	0.000341	0.00263	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—TLR9—malaria	0.000341	0.00263	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000336	0.00259	CbGpPWpGaD
Orlistat—FASN—Disease—PKLR—malaria	0.000335	0.00258	CbGpPWpGaD
Orlistat—Nausea—Quinidine barbiturate—malaria	0.000335	0.00132	CcSEcCtD
Orlistat—Nausea—Pentoxifylline—malaria	0.000334	0.00132	CcSEcCtD
Orlistat—PLA2G4A—Hemostasis—HBB—malaria	0.000334	0.00257	CbGpPWpGaD
Orlistat—FASN—Metabolism—HBB—malaria	0.000315	0.00243	CbGpPWpGaD
Orlistat—DAGLB—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—malaria	0.000302	0.00233	CbGpPWpGaD
Orlistat—DAGLA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—malaria	0.000302	0.00233	CbGpPWpGaD
Orlistat—FASN—Disease—G6PD—malaria	0.000299	0.0023	CbGpPWpGaD
Orlistat—PNLIP—Disease—DHFR—malaria	0.000299	0.0023	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—TLR9—malaria	0.000282	0.00218	CbGpPWpGaD
Orlistat—FASN—Metabolism—PKLR—malaria	0.000281	0.00216	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—HPGDS—malaria	0.00027	0.00208	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—IL2—malaria	0.000259	0.002	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—IL2—malaria	0.000259	0.002	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—DHFR—malaria	0.00025	0.00193	CbGpPWpGaD
Orlistat—FASN—Metabolism—G6PD—malaria	0.00025	0.00193	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—SCARB1—malaria	0.000248	0.00191	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—CD36—malaria	0.000247	0.0019	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—FAS—malaria	0.000244	0.00188	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—CD36—malaria	0.000226	0.00174	CbGpPWpGaD
Orlistat—FASN—Disease—DHFR—malaria	0.000212	0.00163	CbGpPWpGaD
Orlistat—FASN—Metabolism—HPGDS—malaria	0.000191	0.00147	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—DHODH—malaria	0.000187	0.00144	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—HPGDS—malaria	0.000184	0.00142	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—ACKR1—malaria	0.00018	0.00139	CbGpPWpGaD
Orlistat—FASN—Metabolism—DHFR—malaria	0.000177	0.00136	CbGpPWpGaD
Orlistat—FASN—Metabolism—SCARB1—malaria	0.000175	0.00135	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—SCARB1—malaria	0.000169	0.0013	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—IL2—malaria	0.000164	0.00126	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—IL2—malaria	0.000164	0.00126	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—SLC4A1—malaria	0.000159	0.00123	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—CD36—malaria	0.000156	0.0012	CbGpPWpGaD
Orlistat—PNLIP—Disease—NOS2—malaria	0.000153	0.00118	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—DECR1—malaria	0.00015	0.00115	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—IL2—malaria	0.000149	0.00115	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—IL2—malaria	0.000149	0.00115	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—KDR—malaria	0.000136	0.00105	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—KDR—malaria	0.000136	0.00105	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—HBB—malaria	0.000135	0.00104	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—IL2—malaria	0.000127	0.000975	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PKLR—malaria	0.000121	0.000929	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—CD36—malaria	0.000116	0.000897	CbGpPWpGaD
Orlistat—PNLIP—Disease—CD4—malaria	0.000113	0.000871	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—KDR—malaria	0.000112	0.000866	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—HPGDS—malaria	0.000112	0.000865	CbGpPWpGaD
Orlistat—FASN—Metabolism—CD36—malaria	0.00011	0.000848	CbGpPWpGaD
Orlistat—FASN—Disease—NOS2—malaria	0.000108	0.000832	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—G6PD—malaria	0.000107	0.000828	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—ACKR1—malaria	0.000106	0.000819	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—CD36—malaria	0.000106	0.000817	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—malaria	0.000104	0.000798	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—NOS2—malaria	9.57e-05	0.000738	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—IL2—malaria	8.79e-05	0.000677	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—IL2—malaria	8.79e-05	0.000677	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—IL6—malaria	8.75e-05	0.000674	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—IL6—malaria	8.75e-05	0.000674	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TLR9—malaria	8.57e-05	0.00066	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—HPGDS—malaria	8.19e-05	0.000631	CbGpPWpGaD
Orlistat—FASN—Disease—CD4—malaria	8e-05	0.000616	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—DHFR—malaria	7.6e-05	0.000586	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—SCARB1—malaria	7.52e-05	0.00058	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—IL2—malaria	7.29e-05	0.000561	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—IL2—malaria	6.52e-05	0.000503	CbGpPWpGaD
Orlistat—PNLIP—Disease—IL6—malaria	6.11e-05	0.000471	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—IL6—malaria	5.17e-05	0.000398	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—IL6—malaria	5.17e-05	0.000398	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CD36—malaria	4.72e-05	0.000364	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—DHODH—malaria	4.38e-05	0.000338	CbGpPWpGaD
Orlistat—FASN—Disease—IL6—malaria	4.33e-05	0.000333	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—IL6—malaria	4.28e-05	0.00033	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—IL2—malaria	3.74e-05	0.000289	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—SLC4A1—malaria	3.73e-05	0.000287	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—DECR1—malaria	3.5e-05	0.00027	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—KDR—malaria	3.41e-05	0.000263	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—HBB—malaria	3.17e-05	0.000244	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PKLR—malaria	2.82e-05	0.000218	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—G6PD—malaria	2.52e-05	0.000194	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IL2—malaria	2.21e-05	0.00017	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—IL6—malaria	2.2e-05	0.00017	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—HPGDS—malaria	1.92e-05	0.000148	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—DHFR—malaria	1.78e-05	0.000137	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—SCARB1—malaria	1.76e-05	0.000136	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IL6—malaria	1.3e-05	0.0001	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CD36—malaria	1.11e-05	8.52e-05	CbGpPWpGaD
